Eupraxia Pharmaceuticals Inc.
EPRXF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38 | -$24 | -$23 | -$4 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$0 | $1 | $0 |
| Stock-Based Comp. | $1 | $1 | $4 | $0 |
| Change in WC | $7 | $2 | -$0 | $2 |
| Other Non-Cash | $3 | $1 | $3 | $2 |
| Operating Cash Flow | -$28 | -$19 | -$15 | -$0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$0 | -$9 | $0 |
| Inv. Sales/Matur. | $0 | $9 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$5 | -$0 |
| Investing Cash Flow | -$0 | $9 | -$14 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $29 | $13 | $38 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $21 | $14 | $50 | -$1 |
| Financing Cash Flow | $28 | $14 | $50 | -$1 |
| Forex Effect | $1 | $0 | -$0 | -$0 |
| Net Chg. in Cash | $1 | $4 | $21 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25 | $21 | $0 | $1 |
| End Cash | $26 | $25 | $21 | $0 |
| Free Cash Flow | -$28 | -$19 | -$15 | -$0 |